Studies | Sensitivity (95% CrI) | Specificity (95% CrI) | + LR (95% CrI) | − LR (95% CrI) | DOR (95% CrI) | RD (95% CrI) | AUC (95% CrI) | |
---|---|---|---|---|---|---|---|---|
All studies (14) | 0.74 (0.62–0.84) | 0.84 (0.76–0.90) | 4.58 (2.78–9.47) | 0.34 (0.23–0.46) | 15.22 (6.74–42.20) | 0.55 (0.43–0.70) | 0.62 (0.41–0.76) | |
Study design | ||||||||
Prospective (9) | 0.65 (0.51–0.81) | 0.76 (0.70–0.82) | 2.75 (2.47–3.21) | 0.47 (0.24–0.62) | 6.68 (4.00–13.18) | 0.41 (0.30–0.56) | 0.73 (0.67–0.85) | |
Non-prospective (5) | 0.82 (0.66–0.92) | 0.91 (0.74–0.99) | 9.36 (2.48–24.05) | 0.17 (0.07–0.27) | 57.21 (16.26–134.38) | 0.67 (0.53–0.78) | 0.69 (0.30–0.95) | |
Blinding or not | ||||||||
Blinding (5) | 0.68 (0.43–0.89) | 0.76 (0.68–0.82) | 2.97 (2.49–3.53) | 0.37 (0.24–0.55) | 9.18 (4.62–14.49) | 0.48 (0.35–0.58) | 0.76 (0.64–0.82) | |
Non-blinding (9) | 0.77 (0.65–0.88) | 0.88 (0.78–0.96) | 6.29 (3.89–12.03) | 0.25 (0.17–0.32) | 28.64 (12.26–72.31) | 0.65 (0.55–0.77) | 0.64 (0.24–0.89) | |
Population settings | ||||||||
CPB surgery (4) | 0.73 (0.45–0.93) | 0.77 (0.62–0.90) | 4.06 (2.10–7.53) | 0.41 (0.31–0.64) | 11.75 (3.50–23.51) | 0.47 (0.27–0.61) | 0.75 (0.49–0.90) | |
Emergency and critical patients (4) | 0.62 (0.365–0.857) | 0.79 (0.66–0.91) | 3.79 (1.00–6.96) | 0.44 (0.22–0.72) | 13.25 (2.82–31.69) | 0.45 (0.22–0.68) | 0.61 (0.44–0.80) | |
Others (6) | 0.80 (0.66–0.91) | 0.89 (0.75–0.97) | 7.73 (5.28–13.56) | 0.18 (0.16–0.22) | 44.44 (24.23–85.74) | 0.71 (0.66–0.79) | 0.75 (0.54–0.91) | |
Assay method | ||||||||
ELISA (12) | 0.78 (0.68–0.88) | 0.85 (0.75–0.92) | 5.59 (3.05–10.18) | 0.26 (0.15–0.34) | 25.04 (10.33–65.82) | 0.63 (0.52–0.77) | 0.66 (0.41–0.89) | |
Non-ELISA (2) | 0.45 (0.27–0.65) | 0.80 (0.72–0.86) | 2.43 (2.35–2.51) | 0.65 (0.62–0.67) | 3.78 (3.50–4.05) | 0.28 (0.26–0.30) | 0.55 (0.53–0.57) |